Gene · 7033
Papers3,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retraction Notice to: Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3. | Mol Ther Nucleic Acids | 2023 | 36589711 | PubTator, text mining | PubMed |
| Expression of trefoil factor 2 and 3 and adrenomedullin in chronic periodontitis subjects with coronary heart disease. | J Periodontol | 2023 | 36565448 | PubTator, text mining | PubMed |
| EVs vs. EVs: MSCs and Tregs as a source of invisible possibilities. | J Mol Med (Berl) | 2023 | 36527475 | PubTator, text mining | PubMed |
| Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study. | Clin Chem | 2023 | 36508319 | PubTator, text mining | PubMed |
| A Pro-Regenerative Environment Triggers Premalignant to Malignant Transformation of Senescent Hepatocytes. | Cancer Res | 2023 | 36449018 | PubTator, text mining | PubMed |
| The genetics of monogenic intestinal epithelial disorders. | Hum Genet | 2023 | 36422736 | PubTator, text mining | PubMed |
| Real-World Practice of Gastric Cancer Prevention and Screening Calls for Practical Prediction Models. | Clin Transl Gastroenterol | 2023 | 36413795 | PubTator, text mining | PubMed |
| Expression pattern of secretory-cell-related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomes. | Mol Oncol | 2023 | 36349418 | PubTator, text mining | PubMed |
| Single-cell Transcriptomics Reveals Early Molecular and Immune Alterations Underlying the Serrated Neoplasia Pathway Toward Colorectal Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 36216310 | PubTator, text mining | PubMed |
| Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn's Disease. | Inflamm Bowel Dis | 2023 | 36206201 | PubTator, text mining | PubMed |
| NOX1 is essential for TNFα-induced intestinal epithelial ROS secretion and inhibits M cell signatures. | Gut | 2023 | 36191961 | PubTator, text mining | PubMed |
| Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study. | ESC Heart Fail | 2023 | 36184749 | PubTator, text mining | PubMed |
| Skin Tape Strip Proteomics in Mycosis Fungoides Identifies Tumor-Associated Biomarkers. | J Invest Dermatol | 2023 | 36055402 | PubTator, text mining | PubMed |
| VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma. | Biomol Biomed | 2023 | 36036061 | PubTator, text mining | PubMed |
| Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype. | Gut | 2023 | 35944927 | PubTator, text mining | PubMed |
| Defining the key intrahepatic gene networks in HCV infection driven by sex. | Gut | 2023 | 35613843 | PubTator, text mining | PubMed |
| Evaluation of trefoil factor 3 as a non-invasive biomarker of gastric intestinal metaplasia and gastric cancer in a high-risk population. | Gastroenterol Hepatol | 2023 | 35580739 | PubTator, text mining | PubMed |
| A Randomized Double-blind Clinical Trial of Weierkang Pills for the Treatment of Chronic Atrophic Gastritis. | J Clin Gastroenterol | 2023 | 35050943 | PubTator, text mining | PubMed |
| Artificial Intelligence and the Future of Gastroenterology and Hepatology. | Gastro Hep Adv | 2022 | 39132066 | PubTator, text mining | PubMed |
| Role of Immunohistochemistry in Suspected Pancreatic Ductal Adenocarcinoma: A Prospective Study on Fine Needle Aspiration Biopsies. | Pancreas | 2022 | 37099781 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7033/papers?page=24